Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/5195
Title: | Comparison of initial efficacy and long-term follow-up of heparin-coated Jostent with conventional NIR stent | Authors: | Semiz, Ender. Ermiş, C. Yalçinkaya, S. Sancaktar, O. Deger, N. |
Keywords: | Coating Coronary disease Coronary stents Heparin Restenosis heparin biomaterial acute heart infarction adult aged article cardiovascular surgery comparative study controlled study coronary artery bypass graft coronary artery disease coronary stent emergency treatment female human long term care major clinical study male material coating mortality outcomes research priority journal restenosis thrombosis coronary artery thrombosis follow up heart muscle revascularization middle aged retrospective study stent Aged Coated Materials, Biocompatible Coronary Disease Coronary Restenosis Coronary Thrombosis Female Follow-Up Studies Humans Male Middle Aged Myocardial Revascularization Retrospective Studies Stents |
Abstract: | The implantation of heparin-coated stents was reported to be well tolerated, but there are conflicting results about acute in-hospital complications, (sub)acute thrombosis rates, and long-term follow-up compared to uncoated stents. We compared the angiographic and clinical results after coronary placement of two stent models: the heparin-coated premounted Jostent and the uncoated premounted NIR stent. Of 710 patients revascularized, a total of 426 patients received Jostent (n = 230) or NIR stent (n = 196) implantation. The primary end points were acute or subacute thrombosis, urgent CABG, AMI or death, while the secondary end points were the comparison of the restenosis rates of the stents at the 6th month and of the functional angina classification of the stent groups at the 1st, 6th and 12th months. There were no significant differences between the Jostent and NIR stent groups regarding angiographic and procedural success. Acute thrombosis rates in the Jostent and NIR stent groups were similar while no subacute thrombosis was observed in either group. The major adverse cardiac event rates of the groups also did not differ. Angiographic restenosis occurred in 17% of the Jostent group and 16% of the NIR stent group (NS). The combined clinical and angiographic restenosis rate was also similar between the Jo and NIR groups (19% and 18%, respectively). Comparison of functional angina classes at the 1st, 6th and 12th months revealed no significant difference between the study groups. In conclusion, when compared with implantation of an uncoated premounted NIR stent, implantation of a heparin-coated premounted Jostent does not provide any more benefit with respect to initial efficacy, sub(acute) thrombosis and 6-month restenosis rates and 12-month clinical outcomes. Copyright © 2004 by the Japanese Heart Journal. | URI: | https://hdl.handle.net/11499/5195 https://doi.org/10.1536/jhj.44.889 |
ISSN: | 0021-4868 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
44_889.pdf | 79.93 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
8
checked on Sep 30, 2024
WEB OF SCIENCETM
Citations
6
checked on Oct 8, 2024
Page view(s)
26
checked on Aug 24, 2024
Download(s)
16
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.